Trellus Health PLC ( ($GB:TRLS) ) has shared an update. Trellus Health PLC has signed a 12-month contract with a leading global clinical research ...

Inflammatory bowel disease (IBD) is a crowded drug market with plenty of treatment options across the two forms of the ...

Trellus Health PLC has signed a 12-month contract with a leading global clinical research organization to utilize its Trellus TrialSet™ offering, focusing on immunology and inflammation for two ...

GLP-1RA use, compared with basal insulin and DPP-4i use, was associated with lower risks for IBD and hospitalization in type 2 diabetes.

Tulisokibart was linked to clinical, endoscopic and histologic remission in patients with ulcerative colitis following 12 ...

Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner’s National Priority Voucher ...

Insilico announced the launch of its innovative cardiometabolic disease portfolio of unique highly-differentiated molecules ...

A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...

For years, reactions to histamine-rich foods like red wine, aged cheeses, and dark chocolate were dismissed as vague ...

Dr David Liska, Chair of the Department of Colorectal Surgery at the Cleveland Clinic, presents the Ian Lavery Master ...

A groundbreaking study aimed at understanding why Black women in the U.S. are more likely to die from certain cancers than any other racial or ethnic group is gaining traction in Ohio.

BACKGROUND: Current guidelines recommend a stepwise strategy to achieve low-density lipoprotein cholesterol (LDL-C) goals after acute coronary syndrome (ACS). Earlier intensive strategies based on a ...